Novartis 2019 guidance raises, helped by Sandoz generics unit


PHOTO FILE: Switzerland Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS / Arnd Wiegmann / File Photo

ZURICH (Reuters) – Novartis (NOVN.S) lifted full-year on oz ozoz ozoz oz oz oz oz oz

Forecast by 10 analysts in Refinitiv hole. T

The Basel-based company now expects 201% core t Sales expectations were also available.

Novartis highlights performance at Sandoz, where it says international business offset price declines in the United States.

It 's revised Sandoz 2019 sales forecasts upwards – last year. T

“Chief Executive Vas Narasimhan in a statement.

Reporting by John Miller; Neghaiwi. T

Our Standards:The Thomson Reuters Trust Principles.

(tagsToTranslate) US (t) NOVARTIS (t) RESULTS (T) Medical Equipment: (TRBC) (t) Performance / Results (t) Switzerland (t) Company News (t) t) Western Europe (t) Pharmaceuticals (TRBC) (t) Dividends (t) Europe (t) Pharmaceuticals and Medical Research (TRBC) (t) Healthcare (TRBC)


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.